Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9894
+0.0074 (0.75%)
At close: Sep 23, 2026, 4:00 PM EDT
0.9620
-0.0274 (-2.77%)
Pre-market: Sep 24, 2026, 6:29 AM EDT
Werewolf Therapeutics Employees
Werewolf Therapeutics had 14 employees as of March 31, 2026. The number of employees decreased by 25 or -64.10% since the number was last reported on December 31, 2025.
Employees
14
Change
-25
Growth
-64.10%
Revenue / Employee
$1,500,000
Profits / Employee
-$2,472,357
Market Cap
48.08M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 14 | -25 | -64.10% |
| Dec 31, 2025 | 39 | -7 | -15.22% |
| Dec 31, 2024 | 46 | -1 | -2.13% |
| Dec 31, 2023 | 47 | 1 | 2.17% |
| Dec 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Metagenomi Therapeutics | 113 |
| Mereo BioPharma Group | 39 |
| Elicio Therapeutics | 33 |
| PDS Biotechnology | 21 |
| Instil Bio | 17 |
| Edesa Biotech | 17 |
| Apollomics | 14 |
| Dogwood Therapeutics | 8 |
HOWL News
- 14 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Personalis, Inc. (Nasdaq – PSNL), Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX) - GlobeNewsWire
- 4 weeks ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Werewolf Therapeutics, Inc. (Nasdaq – HOWL), Beazer Homes USA, Inc. (NYSE – BZH), MarketAxess Holdings Inc. (Nasdaq – MKTX), CBIZ, Inc. (NYSE – CBZ) - GlobeNewsWire
- 4 weeks ago - Why Werewolf Therapeutics stock exploded higher and what comes next? - Invezz
- 4 weeks ago - Why Is Penny Stock Werewolf Therapeutics (HOWL) Up Today? - TipRanks
- 4 weeks ago - Werewolf Therapeutics, Ambros Therapeutics to combine in all-stock transaction - TheFly
- 4 weeks ago - Werewolf Therapeutics and Ambros Therapeutics Announce Merger Agreement and Concurrent Oversubscribed $150 million Private Placement - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 7 weeks ago - Werewolf Therapeutics Quarterly report: Q2 2026 - Filings